ÂÜÀòÂÒÂ×

Nagjie Alijaj is a highly skilled professional with a focus on cancer research and antibody discovery. Currently serving as a Screening Expert in Antibody Discovery at CDR-Life Inc. since October 2022, Nagjie previously held the position of Postdoctoral Researcher at the University of Zurich from June 2020 to June 2022, where Nagjie was recognized as an SNSF BRIDGE Fellow and UZH Entrepreneur Fellow, contributing to the development of an innovative urine test for prostate cancer screening. Earlier experience includes a PhD in Cancer Biology at Kinderspital Zürich, focusing on novel targeting treatment strategies for rhabdomyosarcoma, and a trainee role at NOXXON Pharma AG, where development and optimization of a method for qualitative analysis of RNA-protein conjugates were undertaken. Nagjie’s educational background includes a Master of Science in Molecular and Cellular Biology from the University of Konstanz and a Bachelor of Science in Biology from The Julius Maximilians University of Würzburg, along with a chemistry laboratory technician apprenticeship at Südzucker AG.